BioNano Genomics Inc vs Kingsoft Cloud Holdings Limited — how do they compare? BioNano Genomics Inc trades at $1.15 (market cap $13.20M), while Kingsoft Cloud Holdings Limited trades at $10.02 (market cap $2.93B). The key difference: Kingsoft Cloud Holdings Limited is far larger — about 222× BioNano Genomics Inc's market cap, and Kingsoft Cloud Holdings Limited is trading nearer its 52-week high, BioNano Genomics Inc nearer its low. Which is the better fit depends on your goals.
| BNGO | KC | |
|---|---|---|
Market Cap | $13.20M | $2.93B |
Sector | Health | Technology |
52-Week High | $4.92 | $18.21 |
52-Week Low | $1.09 | $8.58 |
Enterprise Value | $15.81M | $3.23B |
Signals from Pluang's Aura AI — not financial advice
Bionano Genomics (BNGO) trades at $1.17, down 2.5% today, but maintains a bullish technical signal with strong moving average support. The company shows improving fundamentals with revenue stabilizing around $29M annually and narrowing losses, though it remains unprofitable with a -109.95% net margin. Recent positive developments include debt retirement and growing adoption of optical genome mapping technology.
BNGO presents a high-risk, high-reward opportunity with analyst consensus leaning bullish (57% buy ratings). The stock trades at attractive valuation multiples (P/S 0.31, P/B 0.36) but faces execution risks in achieving profitability. Key catalysts include continued technology adoption and potential margin improvement, while persistent losses and competitive pressures remain concerns.
Kingsoft Cloud (KC) trades at $10.39, down 4.77% today, with a bullish technical signal and strong analyst support (70% buy ratings). Recent quarters show consistent earnings beats, though the company remains unprofitable with a -9.39% net margin. Revenue growth is robust, driven by AI cloud demand, while cash flow from operations improved to $3.80B in 2025. Technical indicators suggest bullish momentum with support near $10 and resistance at $11.
The stock presents a growth opportunity amid China's AI expansion, but profitability challenges and high valuation multiples pose risks. Analyst consensus points to 25.4% upside potential, though execution on margin improvement is critical for sustained gains. Macroeconomic and regulatory factors in China remain key watchpoints for investors.
Trailing returns across standard periods
Latest headlines on both assets
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →Kingsoft Cloud is a leading independent cloud service provider in China. It offers a comprehensive suite of cloud products and solutions tailored for industries like gaming, video streaming, and financial services.
Read more on KC →